Patents Assigned to Eli Lilly Industries Limited
  • Treating immediate hypersensitivity conditions with 3,5-disubstituted hydantoin derivatives
    Patent number: 4230716
    Abstract: Hydantoin compounds are described of the formula (I) : ##STR1## wherein R.sup.1 is phenyl, C.sub.1-4 hydroxyalkyl or carboxy C.sub.1-4 alkyl and wherein R.sub.2 is C.sub.1-6 alkyl. The compounds are useful in the prophylactic treatment of immediate hypersensitivity diseases including asthma.
    Type: Grant
    Filed: May 14, 1979
    Date of Patent: October 28, 1980
    Assignee: Eli Lilly Industries Limited
    Inventors: William B. Jamieson, William J. Ross, Robin G. Simmonds, John P. Verge
  • Cyanomethyl substituted benzoxazoles
    Patent number: 4021440
    Abstract: The invention provides novel 5- and 6-benzoxazolyl alkanoic acids, optionally substituted in the 2-position, and derivatives thereof which possess anti-inflammatory, anti-pyretic and analgesic activity. Also provided is a process for preparing such compounds by cyclizing an appropriately substituted o-aminophenol and, if necessary, converting the resultant benzoxazole to the desired compound.
    Type: Grant
    Filed: June 17, 1975
    Date of Patent: May 3, 1977
    Assignee: Eli Lilly Industries Limited
    Inventors: Delme Evans, David William Dunwell, Terence Alan Hicks